The use of GLP-1 medications has increased rapidly in recent years, with estimates suggesting there are millions of users globally and around 1.6 million in the UK alone, according to University College London
Hanson MC, Crespo MP, Abraham W, Moynihan KD, Szeto GL, Chen SH, et al
The brand's lander references "Semaglutide+" as a program name, but specific drug names and dosages aren't confirmed in publicly accessible FeelGood documentation reviewed for this article
Oral orfoglipron, as opposed to peptide-based oral semaglutide, can be taken without regard to food timing
Aside from the cosmetic effects, an IV antioxidant treatment gives the body a huge boost in immunity